Information de reference pour ce titreAccession Number: | 00002281-201107000-00009.
|
Author: | Tadema, Henko a; Heeringa, Peter b; Kallenberg, Cees GM a
|
Institution: | (a)Department of Rheumatology and Clinical Immunology, The Netherlands (b)Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
|
Title: | |
Source: | Current Opinion in Rheumatology. 23(4):366-371, July 2011.
|
Abstract: | Purpose of review: Wegener's granulomatosis is associated with bacterial infection, in particular nasal carriage of Staphylococcus aureus. Infection may play a role in the induction of autoimmunity as well as in the effector phase of the disease. Here, the current hypotheses aiming to explain the link between infections and Wegener's granulomatosis immunopathogenesis are reviewed and discussed.
Recent findings: In recent years, studies suggested that molecular mimicry could play a role in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV), either via direct mimicry between human lysosome-associated membrane protein-2 and bacterial FimH or indirectly via the development of antibodies against a peptide complementary to proteinase 3 (cPr3). More recent work has focused on Toll-like receptors (TLRs), a family of receptors specialized in the recognition of pathogen-associated molecular patterns. In animal models, it has been shown that TLR ligands can aggravate anti-MPO antibody-mediated disease. Furthermore, it was shown that a TLR9 ligand can trigger the production of ANCA in vitro by peripheral blood-derived B lymphocytes from AAV patients. The newly described process of ANCA-mediated neutrophil extracellular trap formation may provide an endogenous TLR9 ligand. Finally, TLR2 signaling is involved in the development of a Th17-driven immune response, consistent with skewing towards a Th17 T cell phenotype that has been observed in Wegener's granulomatosis.
Summary: Although Wegener's granulomatosis pathophysiology is becoming better understood, the specific events leading to autoimmunity are not clear. Recent studies show that several mechanisms may be involved in linking infection to autoimmunity. Molecular mimicry may be involved, and a role for TLR signaling is suggested.
(C) 2011 Lippincott Williams & Wilkins, Inc.
|
Author Keywords: | infection; Pr3-ANCA; Staphylococcus aureus; Toll-like receptors; Wegener's granulomatosis.
|
References: | 1 Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192.
2 Heeringa P, Tervaert JW. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 2004; 65:1564-1567.
3 Kallenberg CG. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 2008; 30:29-36.
4 Falk RJ, Terrell RS, Charles LA, Jennette JC. Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990; 87:4115-4119.
5 Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 2002; 4:69-83.
6 Van der Veen BS, Chen M, Muller R, et al. Effects of p38 mitogen-activated protein kinase inhibition on antineutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo. Ann Rheum Dis 2011; 70:356-365.
7 Lamprecht P, Wieczorek S, Epplen JT, et al. Granuloma formation in ANCA-associated vasculitides. APMIS Suppl 2009:32-36.
8 Wegener F. Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems under Nieren. Beitr Pathol 1939; 102:36-68.
9 Pinching AJ, Rees AJ, Pussell BA, et al. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980; 281:836-838.
10 Dowell SF, Ho MS. Seasonality of infectious diseases and severe acute respiratory syndrome: what we don't know can hurt us. Lancet Infect Dis 2004; 4:704-708.
11 Aries PM, Herlyn K, Reinhold-Keller E, Latza U. No seasonal variation in the onset of symptoms of 445 patients with Wegener's granulomatosis. Arthritis Rheum 2008; 59:904.
12 Stegeman CA, Tervaert JW, Sluiter WJ, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994; 120:12-17.
13 Zycinska K, Wardyn KA, Zielonka TM, et al. Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. J Physiol Pharmacol 2008; 59(Suppl 6):825-831.
14* Laudien M, Gadola SD, Podschun R, et al. Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener's granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol 2010; 28:51-55. A recent study that confirms the original findings by Stegeman et al. from 1994. The authors found nasal carriage of S. aureus in 72% of patients with Wegener's granulomatosis, and observed increased relapse rates in patients who were nasal S. aureus carriers.
15 Richter AG, Stockley RA, Harper L, Thickett DR. Pulmonary infection in Wegener's granulomatosis and idiopathic pulmonary fibrosis. Thorax 2009; 64:692-697.
16 Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335:16-20.
17* Zycinska K, Wardyn KA, Zielonka TM, et al. Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement. Eur J Med Res 2009; 14(Suppl 4):265-267. A recent study confirming that antibacterial treatment with co-trimoxazole reduces the risk for relapses in patients with Wegener's granulomatosis.
18 Lidar M, Lipschitz N, Langevitz P, et al. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci 2009; 1173:649-657.
19 Zycinska K, Wardyn KA, Zycinski Z, Smolarczyk R. Correlation between Helicobacter pylori infection and pulmonary Wegener's granulomatosis activity. J Physiol Pharmacol 2008; 59(Suppl 6):845-851.
20 Blank M, Barzilai O, Shoenfeld Y. Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 2007; 32:111-118.
21 Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366:1653-1666.
22 Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366:155-168.
23 Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010; 62:2662-2672.
24 Mikuls TR, Payne JB, Reinhardt RA, et al. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009; 9:38-42.
25 Pendergraft WF III, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10:72-79.
26 Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008; 14:1088-1096.
27 Popa ER, Stegeman CA, Abdulahad WH, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford) 2007; 46:1029-1033.
28 Abdulahad WH, Stegeman CA, Kallenberg CG. Review article: the role of CD4(+) T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 2009; 14:26-32.
29 Popa ER, Stegeman CA, Bos NA, et al. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol 2003; 132:496-504.
30 Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008; 58:2196-2205.
31* Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-384. A recent update on Toll-like receptors and their role in pathogen recognition.
32 Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-5396.
33 Stenzel W, Soltek S, Sanchez-Ruiz M, et al. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 2008; 172:132-145.
34 Capolunghi F, Rosado MM, Cascioli S, et al. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. Oxford: Rheumatology; 2010.
35 Hurtado PR, Jeffs L, Nitschke J, et al. CpG oligodeoxynucleotide stimulates production of antineutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol 2008; 9:34.
36* Tadema H, Abdulahad WH, Lepse N, et al. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Oxford: Rheumatology; 2010. A study confirming the previous findings by Hurtado et al., showing that a TLR9 ligand can trigger the production of ANCA autoantibodies by AAV patient derived B lymphocytes in vitro.
37 Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110:955-963.
38 Huugen D, Xiao H, van Esch A, et al. Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 2005; 167:47-58.
39** Summers SA, van der Veen BS, O'Sullivan KM, et al. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 2010; 78:1263-1274. A study that demonstrates a pivotal role for TLR4 in glomerular and lung neutrophil recruitment and injury in experimental ANCA disease.
40** Summers SA, Steinmetz OM, Gan PY, et al. TLR2 induces Th17 myeloperoxidase autoimmunity, while TLR9 drives Th1 autoimmunity. Arthritis Rheum 2011; 63:1124-1135. A follow-up work by Summers et al. showing that TLR2 and TLR9 ligands can drive the development of anti-MPO autoimmunity and vasculitis.
41 Deng J, Ma-Krupa W, Gewirtz AT, et al. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 2009; 104:488-495.
42 Okamoto Yoshida Y, Umemura M, Yahagi A, et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 2010; 184:4414-4422.
43 Niebuhr M, Gathmann M, Scharonow H, et al. Staphylococcal a-toxin is a strong inducer of interleukin (IL)-17 in humans. Infect Immun 2011; 79:1615-1622.
44 Cho JS, Pietras EM, Garcia NC, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120:1762-1773.
45 Horton CG, Pan ZJ, Farris AD. Targeting Toll-like receptors for treatment of SLE. Mediators Inflamm 2010.
46 McCormack WJ, Parker AE, O'Neill LA. Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Res Ther 2009; 11:243.
47 Tadema H, Abdulahad WH, Stegeman CA, et al. Expression of Toll-like receptors 2, 4 and 9 by peripheral blood leukocytes in patients with ANCA-associated vasculitis [abstract]. Arthritis Rheum 2010; 62(Suppl 10):2023.
48 Batsford S, Duermueller U, Seemayer C, et al. Protein level expression of Toll-like receptors 2, 4 and 9 in renal disease. Nephrol Dial Transplant 2011.
49 Schilder AM. Wegener's granulomatosis vasculitis and granuloma. Autoimmun Rev 2010; 9:483-487.
50 Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-1535.
51** Kessenbrock K, Krumbholz M, Schonermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15:623-625. This study demonstrated the capacity of ANCA to induce neutrophil extracellular trap formation.
52 Pilsczek FH, Salina D, Poon KK, et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol 2010; 185:7413-7425.
53 Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416:603-607.
54 Tuon FF, Fernandes ER, Pagliari C, et al. The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma. Parasite Immunol 2010; 32:769-772.
55 Velayudham A, Hritz I, Dolganiuc A, et al. Critical role of Toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol 2006; 45:813-824.
56 Ito T, Schaller M, Hogaboam CM, et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 2009; 119:33-46.
|
Language: | English.
|
Document Type: | Infectious arthritis and immune dysfunction: Edited by Rob Inman.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 1040-8711
|
NLM Journal Code: | 9000851, avg, 9000851
|
DOI Number: | https://dx.doi.org/10.1097/BOR.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|